Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Estimated preventive dose of racemic ketamine for shivering and pruritus prophylaxis in cesarean delivery: a Monte Carlo simulation guided network meta-analysis.

Wang WLiD, Zhou J, Cai Y, Zheng MZ, Chen KY, Hu Y, Men X, Sun JL, Qiu X, Zhou ZF

Frontiers in pharmacologyFeb 4, 2026License: open accessChina1 citationsDOI: 10.3389/fphar.2026.1751842

Abstract

<h4>Background</h4>The use of ketamine and esketamine in cesarean delivery is limited by their dose-dependent adverse effects. This study aimed to precisely quantify the dose-response relationships for the prevention of shivering and pruritus and to determine the associated risk of neuropsychiatric side effects, thereby defining its therapeutic window.<h4>Methods</h4>A systematic review and network meta-analysis were conducted. We searched databases for randomized controlled trials (RCTs) evaluating a single intravenous bolus of ketamine or esketamine during cesarean delivery under neuraxial anesthesia. Study quality was assessed using the Cochrane RoB 2 tool. We integrated traditional and network meta-analysis with logistic regression, Monte Carlo simulation, and polynomial regression to establish continuous dose-response models and calculate key dose parameters (ED<sub>50</sub>, ED<sub>95</sub>).<h4>Results</h4>25 studies(3,842 participants) were included. The ED<sub>50</sub> for preventing pruritus and shivering were 0.122 mg/kg (95% CI, 0.087-0.164) and 0.329 mg/kg (95% CI, 0.260-0.412), respectively. However, at doses of 0.273 mg/kg (ED<sub>50</sub>) and 0.761 mg/kg (ED<sub>95</sub>), 50% and 95% of parturients, respectively, experienced subjective side effects.<h4>Conclusion</h4>The benefits of low-dose ketamine (≈0.12 mg/kg) for pruritus prophylaxis clearly outweigh its risks. In contrast, the dose required for shivering prevention (≈0.33 mg/kg) falls within the range where side effects become common, resulting in a narrow therapeutic window. This study provides critical dose-finding evidence for individualized, goal-directed use of ketamine in cesarean delivery.<h4>Systematic review registration</h4>https://www.crd.york.ac.uk/PROSPERO/view/CRD420251073122, identifier CRD420251073122.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Ketamine

Keywords

Adverse effectsMonte Carlo simulationPruritusShiveringNetwork Meta AnalysisDose-Responses

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.